In:
The Oncologist, Oxford University Press (OUP), Vol. 19, No. 1 ( 2014-01-01), p. 51-60
Kurzfassung:
Describe the association between risk factors for renal cell carcinoma and the outcome of sunitinib treatment for metastatic disease. Explain the impact of active smoking on the outcome of sunitinib-treated metastatic renal cell carcinoma. Discuss obesity, hypertension, and diabetes in relation to the outcome of sunitinib-treated metastatic renal cell carcinoma.
Materialart:
Online-Ressource
ISSN:
1083-7159
,
1549-490X
DOI:
10.1634/theoncologist.2012-0335
Sprache:
Englisch
Verlag:
Oxford University Press (OUP)
Publikationsdatum:
2014
ZDB Id:
2023829-0